Home » Topics » Disease categories and therapies » Dental

Dental
RSS

CSA-13 exhibits potent bactericidal activity against cariogenic and periodontopathic bacteria

March 13, 2009

Osaka University patents compounds for treatment of periodontitis

Nov. 3, 2008

New agents for periodontitis imparted in recent patent

July 1, 2008

FDA approves Oragenics' IND submission for SMaRT Replacement Therapy for tooth decay

Nov. 7, 2007

Kaken and Sunstar sign agreement for bFGF dental product development

June 22, 2007

1-TDC to begin pre-IND studies

Dec. 13, 2006

Sinclair signs agreement to acquire novel anticaries peptide p1025

Dec. 1, 2006

Effects of magnolol on glucosyltransferase explored

Nov. 15, 2006

Novel agents for dental caries claimed by Queen Mary, University of London

Oct. 31, 2006

NV-101 produces faster return of sensation following dental procedures

Oct. 9, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...